These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16079379)

  • 1. An aggrecanase and osteoarthritis.
    Karsenty G
    N Engl J Med; 2005 Aug; 353(5):522-3. PubMed ID: 16079379
    [No Abstract]   [Full Text] [Related]  

  • 2. ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro.
    Stanton H; Rogerson FM; East CJ; Golub SB; Lawlor KE; Meeker CT; Little CB; Last K; Farmer PJ; Campbell IK; Fourie AM; Fosang AJ
    Nature; 2005 Mar; 434(7033):648-52. PubMed ID: 15800625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of aggrecanase and MMP in cartilage degradation].
    Ishiguro N; Kojima T
    Clin Calcium; 2004 Jul; 14(7):38-44. PubMed ID: 15577074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene deletion of either interleukin-1beta, interleukin-1beta-converting enzyme, inducible nitric oxide synthase, or stromelysin 1 accelerates the development of knee osteoarthritis in mice after surgical transection of the medial collateral ligament and partial medial meniscectomy.
    Clements KM; Price JS; Chambers MG; Visco DM; Poole AR; Mason RM
    Arthritis Rheum; 2003 Dec; 48(12):3452-63. PubMed ID: 14673996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cleavage of biglycan by aggrecanases.
    Melching LI; Fisher WD; Lee ER; Mort JS; Roughley PJ
    Osteoarthritis Cartilage; 2006 Nov; 14(11):1147-54. PubMed ID: 16806997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release of hyaluronan and hyaladherins (aggrecan G1 domain and link proteins) from articular cartilage exposed to ADAMTS-4 (aggrecanase 1) or ADAMTS-5 (aggrecanase 2).
    Chockalingam PS; Zeng W; Morris EA; Flannery CR
    Arthritis Rheum; 2004 Sep; 50(9):2839-48. PubMed ID: 15457452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of ADAM-TS4 and ADAM-TS5 prevents aggrecan degradation in osteoarthritic cartilage.
    Malfait AM; Liu RQ; Ijiri K; Komiya S; Tortorella MD
    J Biol Chem; 2002 Jun; 277(25):22201-8. PubMed ID: 11956193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis.
    Glasson SS; Askew R; Sheppard B; Carito B; Blanchet T; Ma HL; Flannery CR; Peluso D; Kanki K; Yang Z; Majumdar MK; Morris EA
    Nature; 2005 Mar; 434(7033):644-8. PubMed ID: 15800624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of human aggrecanase 2 (ADAM-TS5): substrate specificity studies and comparison with aggrecanase 1 (ADAM-TS4).
    Tortorella MD; Liu RQ; Burn T; Newton RC; Arner E
    Matrix Biol; 2002 Oct; 21(6):499-511. PubMed ID: 12392761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variations in aggrecan structure modulate its susceptibility to aggrecanases.
    Roughley PJ; Barnett J; Zuo F; Mort JS
    Biochem J; 2003 Oct; 375(Pt 1):183-9. PubMed ID: 12859252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-6 and its soluble receptor augment aggrecanase-mediated proteoglycan catabolism in articular cartilage.
    Flannery CR; Little CB; Hughes CE; Curtis CL; Caterson B; Jones SA
    Matrix Biol; 2000 Nov; 19(6):549-53. PubMed ID: 11068209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of aggrecanase-generated interglobular domain catabolites in the medium and extracts of cartilage explants using Western blot analysis.
    Hughes CE; Little CB; Caterson B
    Methods Mol Biol; 2003; 225():89-98. PubMed ID: 12769477
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of and osteoarthritis susceptibility in ADAMTS-4-knockout mice.
    Glasson SS; Askew R; Sheppard B; Carito BA; Blanchet T; Ma HL; Flannery CR; Kanki K; Wang E; Peluso D; Yang Z; Majumdar MK; Morris EA
    Arthritis Rheum; 2004 Aug; 50(8):2547-58. PubMed ID: 15334469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADAMTS-4 and ADAMTS-5: key enzymes in osteoarthritis.
    Verma P; Dalal K
    J Cell Biochem; 2011 Dec; 112(12):3507-14. PubMed ID: 21815191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADAMTS-8 exhibits aggrecanase activity and is expressed in human articular cartilage.
    Collins-Racie LA; Flannery CR; Zeng W; Corcoran C; Annis-Freeman B; Agostino MJ; Arai M; DiBlasio-Smith E; Dorner AJ; Georgiadis KE; Jin M; Tan XY; Morris EA; LaVallie ER
    Matrix Biol; 2004 Jul; 23(4):219-30. PubMed ID: 15296936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of metalloprotease cleavage products of human articular cartilage.
    Zhen EY; Brittain IJ; Laska DA; Mitchell PG; Sumer EU; Karsdal MA; Duffin KL
    Arthritis Rheum; 2008 Aug; 58(8):2420-31. PubMed ID: 18668564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation.
    Tortorella MD; Malfait AM; Deccico C; Arner E
    Osteoarthritis Cartilage; 2001 Aug; 9(6):539-52. PubMed ID: 11520168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggrecanase and aggrecan degradation in osteoarthritis: a review.
    Huang K; Wu LD
    J Int Med Res; 2008; 36(6):1149-60. PubMed ID: 19094423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of ADAMTS4 and MT4-MMP indicates that both are involved in aggrecanolysis in interleukin-1-treated bovine cartilage.
    Patwari P; Gao G; Lee JH; Grodzinsky AJ; Sandy JD
    Osteoarthritis Cartilage; 2005 Apr; 13(4):269-77. PubMed ID: 15780640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanisms of degradation of argecanes in osteoarthritic cartilage].
    Lohmander LS; Lark MW; Sandy JD
    Rev Prat; 1996 Mar; 46(6 Spec No):S11-S14. PubMed ID: 8731724
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.